SPDE (Speedus) Total Receivables: $0.06 Mil (As of Sep. 2010)


What is Speedus Total Receivables?

Speedus SPDE -99.00% Total Receivables is $0.06 Mil as of Sep. 2010.

Speedus's Total Receivables for the quarter that ended in Sep. 2010 was $0.06 Mil.

Speedus Total Receivables Historical Data

* Premium members only.

The historical data trend for Speedus's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Speedus Total Receivables Chart

Speedus Annual Data
Trend Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.02 0.06

Speedus Quarterly Data
Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.06 0.07 0.05 0.06

Speedus Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $0.06 Mil mean?
Speedus (SPDE) has a Total Receivables of $0.06 Mil as of Sep. 2010. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Speedus and its competitors.
Is Speedus' Total Receivables too high?
Speedus' current Total Receivables is $0.06 Mil.
How does Speedus' Total Receivables compare to LENSF and WHSI?
Speedus' Total Receivables of $0.06 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Devices & Instruments company?
A good Total Receivables depends on the Medical Devices & Instruments industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Speedus and its competitors. Speedus's current Total Receivables is $0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Speedus stock overvalued right now?
Speedus (SPDE) has a current Total Receivables of $0.06 Mil. The current Total Receivables is $0.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Speedus (SPDE), the current Total Receivables is $0.06 Mil as of Sep. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Speedus Business Description

Address 1 Dag Hammarskjold Boulevard, Freehold, NJ, USA, 07728
Speedus Corp through its subsidiaries focuses on improving health outcomes and cost effectiveness through the development of computer-aided medical devices and telemedicine based delivery systems.